tiprankstipranks

Inspire Medical price target lowered to $235 from $250 at Truist

Inspire Medical price target lowered to $235 from $250 at Truist

Truist lowered the firm’s price target on Inspire Medical (INSP) to $235 from $250 and keeps a Buy rating on the shares. The company’s Q4 results saw a “solid” earnings and gross margin beat, though its profit upside may get overshadowed by a DOJ civil investigative demand, the analyst tells investors in a research note. This could weigh on shares temporarily, but given Inspire’s inflecting profitability and positive cash position, it should be manageable for the stock, Truist added.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue